S

Sangamo Therapeutics
D

SGMO

2.34000
USD
-0.48
(-17.02%)
مغلق
حجم التداول
354,174
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
488,233,676
أصول ذات صلة
    B
    BLUE
    -0.51500
    (-5.75%)
    8.44000 USD
    B
    BMRN
    -2.570
    (-3.82%)
    64.670 USD
    C
    CRSP
    -3.490
    (-7.83%)
    41.110 USD
    E
    EDIT
    -0.17500
    (-11.51%)
    1.34500 USD
    GILD
    GILD
    -2.130
    (-2.30%)
    90.630 USD
    N
    NTLA
    -1.110
    (-8.45%)
    12.020 USD
    المزيد
الأخبار

العنوان: Sangamo Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.